Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities

Amir Reza Safdarian1, Kaveh Momenzadeh2, Farima Kahe3

  • 1Department of Pathology Alborz University of Medical Sciences Alborz Iran.

Clinical Case Reports
|December 28, 2020
PubMed

Insights

This case study highlights the severe risks of COVID-19 in patients with multiple comorbidities like diabetes and epilepsy. Such patients face a high likelihood of developing critical complications, including fatal multiple organ failure.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Internal Medicine

Background:

  • COVID-19 poses increased risks for patients with underlying health conditions, including diabetes and epilepsy.
  • Pre-existing comorbidities significantly influence the severity and prognosis of COVID-19.
  • Understanding the impact of multiple comorbidities on COVID-19 outcomes is critical for patient management.

Observation:

  • * A confirmed COVID-19 case presented with a complex medical history.
  • * The patient had multiple underlying conditions including diabetes, epilepsy, and gout.
  • * The patient experienced rapid deterioration following COVID-19 diagnosis.

Findings:

  • * The patient developed severe complications, including multiple organ failure.
  • * Despite intensive care unit (ICU) admission, the patient's condition worsened.
  • * Death occurred within one week of ICU admission, attributed to multiple organ failure.

Implications:

  • * This case underscores the heightened vulnerability of COVID-19 patients with multiple comorbidities.
  • * Effective treatment strategies for complex COVID-19 cases require consideration of the full patient history.
  • * Multiple organ failure remains a primary cause of mortality in severe COVID-19, particularly in comorbid patients.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
723
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
172